T. Miskowski

发表

Synthesis and SAR of pyridazinone-substituted phenylalanine amide alpha4 integrin antagonists.

E. S. Kimball, P. Hornby, Y. Gong, 2008, Bioorganic & medicinal chemistry letters.

Aza-bicyclic amino acid carboxamides as α4β1/α4β7 integrin receptor antagonists

B. Maryanoff, C. Schneider, B. Damiano, 2005 .

Synthesis and biological evaluation of novel pyridazinone-based alpha4 integrin receptor antagonists.

D. Hlasta, B. Maryanoff, C. Schneider, 2006, Journal of medicinal chemistry.

Identification of potent phenyl imidazoles as opioid receptor agonists.

Sui-Po Zhang, H. Breslin, P. Hornby, 2006, Bioorganic & medicinal chemistry letters.

Discovery of potent cyclic GMP phosphodiesterase inhibitors. 2-Pyridyl- and 2-imidazolylquinazolines possessing cyclic GMP phosphodiesterase and thromboxane synthesis inhibitory activities.

M. Frierson, O. Macina, K. Kondo, 1995, Journal of medicinal chemistry.

Discovery of Potent Cyclic GMP Phosphodiesterase Inhibitors. 2‐Pyridyl‐ and 2‐Imidazolylquinazolines Possessing Cyclic GMP Phoshodiesterase and Thromboxane Synthesis Inhibitory Activities.

M. Frierson, O. Macina, K. Kondo, 1995 .

Tripeptidyl-peptidase II (TPP II) inhibitory activity of (S)-2,3-dihydro-2-(1H-imidazol-2-yl)-1H-indoles, a systematic SAR evaluation. Part 2.

M. Somers, M. Kukla, R. Kavash, 2003, Bioorganic & medicinal chemistry letters.

Triazinediones as prokineticin 1 receptor antagonists. Part 1: SAR, synthesis and biological evaluation.

P. Hornby, J. Palmer, Wei He, 2009, Bioorganic & medicinal chemistry letters.

Identification of a dual δ OR antagonist/μ OR agonist as a potential therapeutic for diarrhea-predominant Irritable Bowel Syndrome (IBS-d).

P. Wade, R. Kavash, Sui-Po Zhang, 2012, Bioorganic & medicinal chemistry letters.

Inhibitor-based validation of a homology model of the active-site of tripeptidyl peptidase II.

R. Kavash, H. De Winter, H. Breslin, 2005, Journal of molecular graphics & modelling.

Antiarthritic profile of BF-389 — A novel anti-inflammatory agent with low ulcerogenic liability

S. J. Lee, M. Frierson, D. Kreutzer, 1992, Agents and Actions.

Identification of potent phenyl imidazoles as opioid receptor agonists.

Sui-Po Zhang, H. Breslin, P. Hornby, 2006, Bioorganic & medicinal chemistry letters.

Rationale, design, and synthesis of novel phenyl imidazoles as opioid receptor agonists for gastrointestinal disorders.

Jian Li, Sui-Po Zhang, H. Breslin, 2004, Journal of medicinal chemistry.